Cesarean Delivery Won’t Harm Kids’ Health: Study: – MONDAY, Oct. 12, 2015 – – In a report greater than 5,000 kids, Australian researchers said they found that cesarean section delivery was not linked with a higher risk of health problems in childhood natural cure for ed . ‘This study shows that some of the previously reported associations between birth by cesarean delivery and adverse childhood health outcomes may be explained by influences apart from mode of birth,’ stated lead researcher Elizabeth Westrupp, a extensive study fellow in the institution of Nursing at La Trobe University in Melbourne. The researchers concluded that cesarean delivery was connected with a mix of negative and positive outcomes through early childhood, and few were consistent.
This conference brings multiple stakeholders collectively, including payers, molecular diagnostics companies, genome analysis/interpretation companies, clinicians and many others in order to provide attendees with a holistic watch of the precision medication landscape. Key topics at this yr's Meeting include: – Finding worth in pharmacogenomics – The challenge of adopting NGS panels – Making RNA sequencing actionable in the clinic – Integration of whole genome sequencing into clinical medicine – Precision healthcare systems – Balancing public and private intellectual property passions in a post Mayo-Myriad age – Precision medication and plan in the building Related StoriesGenetic carrier screening: an interview with Don Hardison, CEO of Great Begin GeneticsAmbry Genetics presents groundbreaking TP53 gene data at ASHG; TP53 associated with breast cancerApplying a high restaurant model to health care communications: an interview with Brandi Robinson, SanofiFeatured Speakers consist of: Robert Green, MD, FACP, Director of Applied Genomics Analysis Informatics, Director, Wellness Heritage Family Medical History Project, Center for Biomedical Study Informatics at NorthShore University Research Institute Gitte Pederson, Chief Executive Officer at Genomic Expression Anya Schiess, MBA, General Co-Founder and Partner at Healthful Ventures Paul Sheives, JD, Vice President, Reimbursement & Regulatory Plan at American Clinical Laboratory Association Elaine Cheung, Director of Strategic Partnerships at Illumina Angela Davies, MD, FRCP , Chief Medical Officer at Champions Oncology Mark Gerstein, Ph.D., Professor of Biomedical Informatics at Yale University Laura Lyman Rodriquez, Ph.D., Director, Office of Policy, Communications and Education at National Individual Genome Analysis Institute Jen Madsen, MPH, Health Policy Advisor at Arnold & Porter Ken Ramos, MD, Ph.D., PharmB, Associate Vice President for Precision Health Sciences, Professor of Medicine at Arizona Health Sciences Middle Birgit Reitmaier, Ph.D., Head of Technology & Biomarkers, Global Licensing & Business Advancement at Merck Serono division, Merck KGaA..